Skip to main content
. 2023 May 6;15:1–13. doi: 10.1016/j.xjon.2023.04.015

Table 3.

Contingency table evaluating the association of lower-extremity revascularization to clinical variables

Variables Frequency of lower-extremity revascularization P value
Gender .54
 Male 12/61 (19.7)
 Female 3/24 (12.5)
Race .73
 White 11/67 (16.4)
 Other 4/18 (22.2)
Hypertension .54
 No 3/25 (12.0)
 Yes 12/60 (20.0)
Diabetes mellitus .60
 No 13/78 (16.7)
 Yes 2/7 (28.6)
Chronic lung disease .14
 No 12/77 (15.6)
 Yes 3/8 (37.5)
Peripheral vascular disease .004
 No 4/52 (7.7)
 Yes 11/33 (33.3)
Atrial fibrillation .59
 No 15/79 (19.0)
 Yes 0/6 (0.00)
Coronary artery disease .37
 No 12/75 (16.0)
 Yes 3/10 (30.0)
Redo heart surgery .10
 No 12/78 (15.4)
 Yes 3/7 (42.9)
Aortic insufficiency moderate or greater .78
 No 8/41 (19.5)
 Yes 7/44 (15.9)
Tamponade, rupture, or shock .02
 No 14/56 (25.0)
 Yes 1/29 (3.5)
Current dialysis .58
 No 15/80 (18.8)
 Yes 0/5 (0.0)
Cerebral malperfusion .34
 No 13/64 (20.3)
 Yes 2/21 (9.5)
Coronary malperfusion .58
 No 15/80 (18.8)
 Yes 0/5 (0.0)
Visceral malperfusion 1.00
 No 13/70 (18.6)
 Yes 2/15 (13.3)
Renal malperfusion 1.00
 No 11/63 (17.5)
 Yes 4/22 (18.2)
Previous lower-extremity intervention .58
 No 15/80 (18.8)
 Yes 0/5 (0.0)
Pulse deficit .01
 No 6/60 (10.0)
 Yes 9/25 (36.0)
Limb affected in LEM .75
 Left 7/23 (30.4)
 Right 5/24 (20.8)
 Both 2/8 (25.0)

LEM, Lower-extremity malperfusion.